{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:22:29Z","timestamp":1794673349522,"version":"4.9.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpurol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Urology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jpurol.2026.106252","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T05:59:54Z","timestamp":1788155994000},"page":"106252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The addition of mirabegron in pediatric lower urinary tract dysfunction: A large single-center experience"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3246-4662","authenticated-orcid":false,"given":"Adree","family":"Khondker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7649-0759","authenticated-orcid":false,"given":"Lisa","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirriam","family":"Mikhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Rickard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando J.","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana Dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jpurol.2026.106252_bib1","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1124\/jpet.106.115840","article-title":"Effect of (R)-2-(2-aminothiazol-4-yl)-4\u2032-{2-[(2-hydroxy-2- phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective \u03b23-adrenoceptor agonist, on bladder function","volume":"321","author":"Takasu","year":"2007","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.jpurol.2026.106252_bib2","series-title":"Highlights of prescribing information","year":"2021"},{"issue":"8","key":"10.1016\/j.jpurol.2026.106252_bib3","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/nau.25532","article-title":"The AUA\/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder","volume":"43","author":"Cameron","year":"2024","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"10.1016\/j.jpurol.2026.106252_bib4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/JU.0000000000002361","article-title":"\u03b23-Adrenoceptor agonist for the treatment of bladder dysfunction in children: a systematic review and meta-analysis","volume":"207","author":"Kim","year":"2022","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.jpurol.2026.106252_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jagp.2017.08.005","article-title":"Reduction of the anticholinergic burden makes it possible to decrease behavioral and psychological symptoms of dementia","volume":"26","author":"Ja\u00efdi","year":"2018","journal-title":"Am J Geriatr Psychiatr"},{"issue":"8","key":"10.1016\/j.jpurol.2026.106252_bib6","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jamainternmed.2019.0677","article-title":"Anticholinergic drug exposure and the risk of dementia: a nested case-control study","volume":"179","author":"Coupland","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.jpurol.2026.106252_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-80211-6","article-title":"The effects of anticholinergic medications on cognition in children: a systematic review and meta-analysis","volume":"11","author":"Ghezzi","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpurol.2026.106252_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijso.2021.100412","article-title":"Efficacy and safety of mirabegron in pediatric population: a systematic review","volume":"37","author":"Nasution","year":"2021","journal-title":"International Journal of Surgery Open"},{"issue":"2","key":"10.1016\/j.jpurol.2026.106252_bib9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jpedsurg.2019.10.044","article-title":"Effectiveness and tolerability of mirabegron in children with overactive bladder: a retrospective pilot study","volume":"55","author":"Fryer","year":"2020","journal-title":"J Pediatr Surg"},{"issue":"3","key":"10.1016\/j.jpurol.2026.106252_bib10","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/JU.0000000000002361","article-title":"\u03b23-Adrenoceptor agonist for the treatment of bladder dysfunction in children: a systematic review and meta-analysis","volume":"207","author":"Kim","year":"2022","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.jpurol.2026.106252_bib11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40272-021-00452-4","article-title":"Mirabegron: pediatric first approval","volume":"23","author":"Keam","year":"2021","journal-title":"Paediatr Drugs [Internet]"},{"issue":"6","key":"10.1016\/j.jpurol.2026.106252_bib12","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/nau.24657","article-title":"Efficacy and safety of mirabegron in children and adolescents with neurogenic detrusor overactivity: an open-label, phase 3, dose-titration study","volume":"40","author":"Baka-Ostrowska","year":"2021","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"10.1016\/j.jpurol.2026.106252_bib13","article-title":"Mirabegron as part of combination therapy for treatment refractory neurogenic bladder in pediatric patients with spina bifida","volume":"21","author":"Gaines","year":"2025","journal-title":"J Pediatr Urol [Internet]"},{"issue":"1","key":"10.1016\/j.jpurol.2026.106252_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.eururo.2016.02.007","article-title":"Prospective pilot study of mirabegron in pediatric patients with overactive bladder","volume":"70","author":"Blais","year":"2016","journal-title":"Eur Urol [Internet]"},{"issue":"2","key":"10.1016\/j.jpurol.2026.106252_bib15","first-page":"206","article-title":"Safety and effectiveness of mirabegron for children and adolescents with refractory idiopathic overactive bladder for improving urinary symptoms: a systematic review","volume":"77","author":"Franco-Buenaventura","year":"2024","journal-title":"Cent European J Urol [Internet]"},{"key":"10.1016\/j.jpurol.2026.106252_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijso.2021.100412","article-title":"Efficacy and safety of mirabegron in pediatric population: a systematic review","volume":"37","author":"Nasution","year":"2021","journal-title":"International Journal of Surgery Open"},{"issue":"Suppl 1","key":"10.1016\/j.jpurol.2026.106252_bib17","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","article-title":"The STROBE guidelines","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"issue":"2","key":"10.1016\/j.jpurol.2026.106252_bib18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jpedsurg.2019.10.044","article-title":"Effectiveness and tolerability of mirabegron in children with overactive bladder: a retrospective pilot study","volume":"55","author":"Fryer","year":"2020","journal-title":"J Pediatr Surg"}],"container-title":["Journal of Pediatric Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513126005310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513126005310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:05:27Z","timestamp":1794672327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477513126005310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1477513126005310"],"URL":"https:\/\/doi.org\/10.1016\/j.jpurol.2026.106252","relation":{},"ISSN":["1477-5131"],"issn-type":[{"value":"1477-5131","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The addition of mirabegron in pediatric lower urinary tract dysfunction: A large single-center experience","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpurol.2026.106252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of Journal of Pediatric Urology Company.","name":"copyright","label":"Copyright"}],"article-number":"106252"}}